The LncRNA-LINC01260 gene can suppress NSCLC tumorigenesis through competitive endogenous RNA and ultimately inhibit NF-κB pathway activation by regulating CYLD expression, providing a potential target for NSCLC treatment [101]. Here, CYLD is linked to non-small cell lung carcinoma.